Published in Tuberc Res Treat on January 19, 2012
Improvement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis. PLoS One (2015) 0.82
Tuberculosis exposure, infection and disease in children: a systematic diagnostic approach. Pneumonia (Nathan) (2016) 0.77
Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis. PLoS One (2017) 0.75
Impact of Larger Sputum Volume on Xpert(®) MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis. J Clin Med (2017) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med (2008) 7.47
HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med (2009) 4.76
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med (2003) 4.36
Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis (2009) 3.37
Better patient instruction for sputum sampling can improve microscopic tuberculosis diagnosis. Int J Tuberc Lung Dis (2005) 2.52
Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis (1993) 2.36
Clinical and laboratory observations of tuberculosis at a Mumbai (India) clinic. Postgrad Med J (2004) 2.36
Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis (1997) 2.07
Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting. Int J Tuberc Lung Dis (2008) 1.85
A minimum 5.0 ml of sputum improves the sensitivity of acid-fast smear for Mycobacterium tuberculosis. Am J Respir Crit Care Med (2000) 1.71
Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. Eur J Clin Microbiol Infect Dis (2010) 1.67
Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Trop Med Int Health (2005) 1.63
Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis. BMC Pulm Med (2001) 1.47
Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community. Curr Opin Infect Dis (2009) 1.46
Comparison of four culture systems for Mycobacterium tuberculosis in the Zambian National Reference Laboratory. Int J Tuberc Lung Dis (2009) 1.37
Management of pulmonary tuberculosis suspects with negative sputum smears and normal or minimally abnormal chest radiographs in resource-poor settings. Int J Tuberc Lung Dis (1998) 1.17
Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid. Trop Med Int Health (2007) 1.05
Validation of bleach-treated smears for the diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2009) 0.90
Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis (2013) 2.43
High throughput multiplex PCR and probe-based detection with Luminex beads for seven intestinal parasites. Am J Trop Med Hyg (2011) 2.10
A laboratory-developed TaqMan Array Card for simultaneous detection of 19 enteropathogens. J Clin Microbiol (2012) 1.99
Giardia assemblage A infection and diarrhea in Bangladesh. J Infect Dis (2005) 1.70
Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infect Dis (2007) 1.66
The future of molecular diagnostics for drug-resistant tuberculosis. Expert Rev Mol Diagn (2012) 1.58
Simultaneous detection of six diarrhea-causing bacterial pathogens with an in-house PCR-luminex assay. J Clin Microbiol (2011) 1.55
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrob Agents Chemother (2008) 1.50
Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA. Emerg Infect Dis (2010) 1.48
Development of a multiplex polymerase chain reaction assay for diarrheagenic Escherichia coli and Shigella spp. and its evaluation on colonies, culture broths, and stool. Diagn Microbiol Infect Dis (2012) 1.43
Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa. Emerg Infect Dis (2011) 1.35
Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. J Clin Microbiol (2013) 1.33
Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries. J Clin Microbiol (2013) 1.30
Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using real-time polymerase chain reaction. Am J Trop Med Hyg (2007) 1.25
Multiplex real-time PCR assay using Scorpion probes and DNA capture for genotype-specific detection of Giardia lamblia on fecal samples. J Clin Microbiol (2005) 1.25
Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes. J Med Microbiol (2006) 1.23
Association between stool enteropathogen quantity and disease in Tanzanian children using TaqMan array cards: a nested case-control study. Am J Trop Med Hyg (2013) 1.15
Disruption of the human gut microbiota following Norovirus infection. PLoS One (2012) 1.13
Multiplex polymerase chain reaction method to detect Cyclospora, Cystoisospora, and Microsporidia in stool samples. Diagn Microbiol Infect Dis (2011) 1.10
Molecular diagnosis of diarrhea: current status and future potential. Curr Infect Dis Rep (2012) 1.07
Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania. PLoS One (2013) 1.06
Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries. J Clin Microbiol (2014) 1.06
Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infect Dis (2011) 1.05
A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target. J Biol Chem (2010) 1.03
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients. Antimicrob Agents Chemother (2013) 1.01
Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut. Am J Pathol (2010) 1.01
Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation. Emerg Infect Dis (2013) 1.00
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. Antimicrob Agents Chemother (2013) 1.00
Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ (2011) 1.00
High prevalence of Entamoeba moshkovskii in a Tanzanian HIV population. Acta Trop (2008) 0.98
Childhood tuberculosis in the Kilimanjaro region: lessons from and for the TB programme. Trop Med Int Health (2010) 0.97
The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS (2007) 0.96
Plasma drug activity assay for treatment optimization in tuberculosis patients. Antimicrob Agents Chemother (2011) 0.95
Calcified neurocysticercus, perilesional edema, and histologic inflammation. Am J Trop Med Hyg (2014) 0.94
Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon. Infect Immun (2009) 0.94
Febrile illness and pro-inflammatory cytokines are associated with lower neurodevelopmental scores in Bangladeshi infants living in poverty. BMC Pediatr (2014) 0.92
CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine. Vaccine (2010) 0.92
The complexity of the adherence-response relationship in tuberculosis treatment: why are we still in the dark and how can we get out? Trop Med Int Health (2011) 0.91
Cryptosporidium parvum bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin. Parasitol Res (2006) 0.90
Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania. BMC Infect Dis (2013) 0.89
Transfer of newborns to neonatal care unit: a registry based study in Northern Tanzania. BMC Pregnancy Childbirth (2011) 0.88
Giardia intestinalis assemblages A and B infections in Nepal. Am J Trop Med Hyg (2009) 0.88
Prevalence and risk factors for infection of bovine tuberculosis in indigenous cattle in the Serengeti ecosystem, Tanzania. BMC Vet Res (2013) 0.87
Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania. J Antimicrob Chemother (2011) 0.87
Infection risk assessment of diarrhea-related pathogens in a tropical canal network. Sci Total Environ (2008) 0.87
Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open (2013) 0.86
Entamoeba histolytica infection and secreted proteins proteolytically damage enteric neurons. Infect Immun (2010) 0.86
18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series. BMC Pulm Med (2013) 0.86
IMS-free DNA extraction for the PCR-based quantification of Cryptosporidium parvum and Giardia lamblia in surface and waste water. Int J Environ Health Res (2007) 0.86
Dual probe DNA capture for sensitive real-time PCR detection of Cryptosporidium and Giardia. Mol Cell Probes (2011) 0.83
Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients. Trop Med Int Health (2010) 0.83
Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment. J Antimicrob Chemother (2010) 0.82
An exploration of patient perceptions of adherence to tuberculosis treatment in Tanzania. Qual Health Res (2012) 0.82
Understanding pharmacokinetics to improve tuberculosis treatment outcome. Expert Opin Drug Metab Toxicol (2014) 0.82
Upper gastrointestinal endoscopic findings and prevalence of Helicobacter pylori infection among adult patients with dyspepsia in northern Tanzania. Tanzan J Health Res (2014) 0.82
Use of mycobacteriophage quantitative PCR on MGIT broths for a rapid tuberculosis antibiogram. J Clin Microbiol (2014) 0.81
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settings. Ther Drug Monit (2015) 0.80
A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania. BMC Infect Dis (2014) 0.79
Optimizing second-line therapy for drug-resistant tuberculosis: the additive value of sequencing for multiple resistance loci. Antimicrob Agents Chemother (2011) 0.79
Tuberculosis cross-species transmission in Tanzania: towards a One-Health concept. Onderstepoort J Vet Res (2012) 0.78
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study. Antivir Ther (2012) 0.78
Rapid detection of pyrazinamide resistant Mycobacterium tuberculosis by high resolution melting curve analysis. J Med Assoc Thai (2013) 0.77
Bovine tuberculosis at the human-livestock-wildlife interface: is it a public health problem in Tanzania? A review. Onderstepoort J Vet Res (2012) 0.77
A Comparison of Diarrheal Severity Scores in the MAL-ED Multisite Community-Based Cohort Study. J Pediatr Gastroenterol Nutr (2016) 0.77
The NF-kappaB p50 subunit is protective during intestinal Entamoeba histolytica infection of 129 and C57BL/6 mice. Infect Immun (2010) 0.76
Efficacy of antiamebic drugs in a mouse model. Am J Trop Med Hyg (2011) 0.76
Early Antibiotic Exposure in Low-Resource Settings is Associated with Increased Weight in The First Two Years of Life. J Pediatr Gastroenterol Nutr (2017) 0.75
Intensified specimen collection to improve tuberculosis diagnosis in children from Rural South Africa, an observational study. BMC Infect Dis (2014) 0.75
Enteroaggregative Escherichia coli quantification in children stool samples using quantitative PCR. APMIS (2012) 0.75
Glycated hemoglobin screening identifies patients admitted for retreatment of tuberculosis at risk for diabetes in Tanzania. J Infect Dev Ctries (2016) 0.75
AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus. BMC Res Notes (2011) 0.75
Determinant Variables, Enteric Pathogen Burden, Gut Function, and Immune-Related Inflammatory Biomarkers Associated with Childhood Malnutrition: A Prospective Case-Control Study in Northeastern Brazil. Pediatr Infect Dis J (2017) 0.75
Having walked the path. Ann Intern Med (2014) 0.75
Molecular techniques in ecohealth research toolkit: facilitating estimation of aggregate gastroenteritis burden in an irrigated periurban landscape. Ecohealth (2011) 0.75
Correction: Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis. PLoS One (2017) 0.75
Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient. Emerg Infect Dis (2019) 0.75
A Systematic Review Of Salivary Versus Blood Concentrations Of Anti-Tuberculosis Drugs And Their Potential For Salivary Therapeutic Drug Monitoring. Ther Drug Monit (2017) 0.75